Daniel Kaul

5.4k total citations
89 papers, 2.5k citations indexed

About

Daniel Kaul is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Daniel Kaul has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 43 papers in Infectious Diseases and 16 papers in Surgery. Recurrent topics in Daniel Kaul's work include Cytomegalovirus and herpesvirus research (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Herpesvirus Infections and Treatments (9 papers). Daniel Kaul is often cited by papers focused on Cytomegalovirus and herpesvirus research (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers) and Herpesvirus Infections and Treatments (9 papers). Daniel Kaul collaborates with scholars based in United States, Canada and Switzerland. Daniel Kaul's co-authors include Michael G. Ison, Sanjay Saint, Powel Kazanjian, Cameron R. Wolfe, Preeti Malani, Christopher J. Sonnenday, Robert Krell, Andrew R. Martin, Michael J. Englesbe and Shijie Cai and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Daniel Kaul

86 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Kaul United States 29 1.4k 835 574 417 248 89 2.5k
Elisa Cordero Spain 32 1.9k 1.4× 1.1k 1.3× 343 0.6× 427 1.0× 392 1.6× 133 3.3k
Pierluca Piselli Italy 28 831 0.6× 402 0.5× 698 1.2× 435 1.0× 132 0.5× 105 2.3k
Francisco López‐Medrano Spain 35 2.4k 1.8× 1.5k 1.8× 417 0.7× 823 2.0× 532 2.1× 213 4.3k
Stefan Reuter Germany 32 738 0.5× 1.0k 1.2× 464 0.8× 1.0k 2.4× 382 1.5× 123 3.4k
Óscar Len Spain 30 1.9k 1.4× 1.0k 1.2× 189 0.3× 591 1.4× 346 1.4× 107 2.6k
Diana F. Florescu United States 28 1.5k 1.1× 925 1.1× 295 0.5× 269 0.6× 223 0.9× 102 2.5k
Sherif B. Mossad United States 25 1.4k 1.0× 844 1.0× 503 0.9× 248 0.6× 92 0.4× 97 2.3k
N. Singh United States 33 2.4k 1.7× 2.0k 2.5× 312 0.5× 539 1.3× 282 1.1× 90 3.5k
Carlos Cervera Spain 42 3.0k 2.2× 1.6k 1.9× 425 0.7× 852 2.0× 750 3.0× 163 4.5k
Christian Garzoni Switzerland 27 932 0.7× 1.3k 1.5× 360 0.6× 326 0.8× 117 0.5× 71 2.7k

Countries citing papers authored by Daniel Kaul

Since Specialization
Citations

This map shows the geographic impact of Daniel Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kaul more than expected).

Fields of papers citing papers by Daniel Kaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kaul. The network helps show where Daniel Kaul may publish in the future.

Co-authorship network of co-authors of Daniel Kaul

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kaul. A scholar is included among the top collaborators of Daniel Kaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kaul. Daniel Kaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danziger‐Isakov, Lara, Anne Rose, Daniel Kaul, et al.. (2024). Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study. Transplant Infectious Disease. 26(3). e14270–e14270.
2.
Aitken, Samuel L, Ji Hoon Baang, Daniel Kaul, et al.. (2023). Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series. Open Forum Infectious Diseases. 10(4). ofad189–ofad189. 17 indexed citations
3.
Chaer, Firas El, Daniel Kaul, Janet A. Englund, et al.. (2023). American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Transplantation and Cellular Therapy. 29(12). 730–738. 15 indexed citations
5.
Frame, David, Thomas Braun, Mary Maliarik, et al.. (2022). Defibrotide Therapy for SARS-CoV-2 ARDS. CHEST Journal. 162(2). 346–355. 11 indexed citations
6.
Ison, Michael G., Emily A. Blumberg, Natasha Halasa, et al.. (2021). Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research. American Journal of Transplantation. 22(1). 24–27. 6 indexed citations
7.
Park, Jeong Mi, et al.. (2020). Increasing net immunosuppression after BK polyoma virus infection. Transplant Infectious Disease. 23(2). e13472–e13472. 7 indexed citations
8.
Kaul, Daniel. (2020). Pharyngeal and Nasal Swabs May Not Have Adequate Sensitivity for SARS-CoV-2. Journal watch. 2020. 1 indexed citations
9.
Kaul, Daniel, Emily A. Blumberg, Ricardo M. La Hoz, et al.. (2020). Ten years of donor-derived disease: A report of the disease transmission advisory committee. American Journal of Transplantation. 21(2). 689–702. 80 indexed citations
10.
11.
Kaul, Daniel. (2017). Letermovir Approved to Prevent CMV Infection and Disease in Transplant Patients. Journal watch. 2017. 1 indexed citations
12.
Levenson, Joshua, Daniel Kaul, Sanjay Saint, Brahmajee K. Nallamothu, & Hitinder S. Gurm. (2013). A Shocking Development. New England Journal of Medicine. 369(23). 2253–2258. 7 indexed citations
13.
Mason, William J., et al.. (2011). Avoiding a Rash Diagnosis. New England Journal of Medicine. 364(5). 466–471. 1 indexed citations
14.
Safdar, Nasia, et al.. (2010). Thinking Inside the Box. New England Journal of Medicine. 363(6). 574–579. 2 indexed citations
15.
16.
Graham, Brian B., Daniel Kaul, Sanjay Saint, & William J. Janssen. (2009). Kiss of Death. New England Journal of Medicine. 360(24). 2564–2568. 35 indexed citations
17.
Reddy, Pavan, et al.. (2008). Biopsy‐proven adenoviral diarrhea responding to low‐dose cidofovir. Transplant Infectious Disease. 10(5). 346–350. 4 indexed citations
18.
Savona, Michael R., Duane W. Newton, David Frame, et al.. (2007). Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplantation. 39(12). 783–787. 83 indexed citations
19.
Kaul, Daniel, et al.. (2006). Ring around the Diagnosis. New England Journal of Medicine. 354(18). 1937–1942. 9 indexed citations
20.
Carver, Peggy L., David Fleisher, Simon Zhou, et al.. (1999). Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients. Pharmaceutical Research. 16(5). 718–724. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026